comprehensive -WSS

comprehensive

author：explore 2025-09-27 10:06:12 - browse：5134

Adobe

WASHINGTON — The federal government increasingly is scrutinizing Chinese businesses and their interactions with American companies, including in the biotech sector. Chinese biotechnology companies, the thinking goes, could threaten national security by giving the Chinese government access to the genetic and health information of Americans.

Just Wednesday, President Biden issued an executive order aimed at keeping sensitive data, including Americans’ genetic information, out of the hands of adversaries.

But American biotech companies worry they could become collateral damage if the government sloppily targets sanctions. They’re pushing back against legislation that would bar biotech companies from working with some Chinese companies, especially as the government takes aim at WuXi, a Chinese company considered a crucial partner for discovering, testing, and making medicines that has worked with such brands as Pfizer, AstraZeneca, and GSK.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Novel spinal cord stimulator treats paralysis without surgery

WSS

What nurses really want: sufficient staffing for patient care

First recipient of genetically engineered pig kidney has died

Most antidepressants don't work on kids, teens, study finds

Brain technologies pose threats that are all too real, experts warn

AI for drug discovery: Experts on separating hype from reality

How to improve immunocompromised access to mAb treatments

knowledge

comprehensive

leisure time

As demand for Covid shots wanes, Moderna seeks its next success

Sanofi strikes deal with Novavax, boosting the vaccine maker

Psychedelics group wrestles with new pharma identity

Warren pushes Witty on UnitedHealth's control over physicians

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Novel spinal cord stimulator treats paralysis without surgery

Trump demands the U.S. pay no more for drugs than other countries … again

Sepsis can kill a child within hours. Here's how hospitals are fighting back

In age of alternative facts, a scholarly course on calling out crap

Researchers on aging grapple with how to calculate biological age

focus

As billionaires fund anti

Crowdfunding for medical bills sidesteps core problem, author says

Brain technologies pose threats that are all too real, experts warn

H5N1 bird flu: what we're starting to learn about infection in cows

Apple Watch's A

As health system earnings go up, health insurance stocks go down

explore

focus

leisure time

focus